Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Islet Studies

Uncoupling Protein 2: A Possible Link Between Fatty Acid Excess and Impaired Glucose-Induced Insulin Secretion?

  1. Nathalie Lameloise1,
  2. Patrick Muzzin1,
  3. Marc Prentki23 and
  4. Françoise Assimacopoulos-Jeannet1
  1. 1Department of Medical Biochemistry, Centre Médical Universitaire, Medical Faculty, University of Geneva, Geneva, Switzerland
  2. 2Molecular Nutrition Unit, Department of Nutrition, University of Montreal
  3. 3CHUM, Centre de Recherche and Institut du Cancer, Montreal, Quebec, Canada
    Diabetes 2001 Apr; 50(4): 803-809. https://doi.org/10.2337/diabetes.50.4.803
    PreviousNext
    • Article
    • Figures & Tables
    • Info & Metrics
    • PDF
    Loading

    Article Figures & Tables

    Figures

    • Tables
    • FIG. 1.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 1.

      Effects of a long-term exposure of INS-1 cells to oleate on insulin secretion in response to glucose, tolbutamide, and KCl. Cells were cultured in RPMI medium containing 10% FCS with 0.5% BSA for 72 h at 5 mmol/l glucose, in the absence or presence of 0.4 mmol/l oleate. They were then incubated for 30 min in KRBH buffer at 2.8 mmol/l glucose (G 2.8), 12 mmol/l glucose (G 12), 2.8 mmol/l glucose + 100 μmol/l tolbutamide (TOLB), or 30 mmol/l KCl (KC1). The insulin contents in cells cultured in the absence or presence of oleate were 231 ± 43 and 190 ± 8 ng/μg DNA, respectively (P < 0.05 by paired t test). Data are means ± SE of 3–5 experiments. **P < 0.02.

    • FIG. 2.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 2.

      Effect of a long-term exposure to oleate on glucose-induced changes in plasma membrane potential. INS-1 cells were cultured in RPMI medium containing 10% FCS with 0.5% BSA for 72 h at 5 mmol/l glucose, in the absence or presence of 0.4 mmol/l oleate. Cells were detached and incubated in KRBH buffer containing 2.8 mmol/l glucose and bisoxonol (100 μmol/l), and fluorescence was used to measure plasma membrane potential. At the indicated time, glucose was added at a final concentration of 12.8 mmol/l and then at 30 mmol/l KCl. Data are from one of four representative experiments.

    • FIG. 3.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 3.

      Effect of a long-term exposure to oleate on the mitochondrial membrane potential (ΔΨm) of INS-1 cells. Cells were cultured in RPMI medium containing 10% FCS with 0.5% BSA for 72 h at 5 mmol/l glucose, in the absence or presence of 0.4 mmol/l oleate, then detached and incubated 30 min in KRBH buffer containing 0.1% BSA and 2.8 mmol/l glucose with the mitochondrial potential sensitive dye TMRE, and analyzed by flow cytometry. CCCP (75 μmol/l) was added to uncouple the cells. A, ΔΨm in the absence of CCCP; B, ΔΨm in the presence of CCCP; Δ, A – B. Data are means of four experiments. *P < 0.05.

    • FIG. 4.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 4.

      Effect of a long-term exposure to oleate on glucose-induced changes in mitochondrial membrane potential (Δψm). INS-1 cells were cultured at 5 mmol/l glucose, in the absence or presence of 0.4 mmol/l oleate, then detached and incubated in KRBH buffer containing 0.1% BSA and 2.8 mmol/l glucose with the mitochondrial membrane potential sensitive dye rhodamine 123. At the indicated times, glucose was added at a final concentration of 12.8 mmol/l. At the end of each trace, CCCP (75 μmol/l) was added to uncouple the cells. Data are from one of four representative experiments.

    • FIG. 5.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 5.

      Distribution and expression of UCP2 in rat tissues and INS-1 cells. A: Comparison of UCP2 mRNA expression in rat tissues and INS-1 cells. UCP2 and 18S mRNA were detected on Northern blots containing 8 μg total RNA per lane and hybridized with 32P-labeled rat UCP2 or 18 S probes. L, liver; S, spleen; K, kidney; WAT, white adipose tissue. B: Comparison of UCP2 protein expression in INS-1 cells, rat pancreatic islets, and purified β-cells. Western blotting was performed with 30 μg protein from INS-1 cells, pancreatic islets, and β-cells using a polyclonal antibody to the COOH-terminal domain of UCP2. C: UCP2 is found in the same cellular fraction as the mitochondrial enzyme cytochrome oxidase. H, homogenate; S, postnuclear supernatant; mit, mitochondrial fraction; PM, crude plasma membrane fraction. Western blotting was performed with 30 μg protein from homogenate and subcellular fractions of INS-1 cells using a polyclonal antibody to the NH2-terminal domain of UCP2.

    • FIG. 6.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 6.

      Effects of oleate, palmitate, bromopalmitate, glucose, and forskolin on UCP2 mRNA expression. INS-1 cells were cultured for 18 h with 0.5% BSA, fatty acid bound to BSA (0.4 mmol/l), 25 mmol/l glucose, or 50 μmol/l forskolin. UCP2 transcript was measured by Northern blotting hybridization on 8 μg total RNA. Cont, control; OL, oleate; Palm, palmitate; BrP, 2-bromopalmitate; G25, 25 mmol/l glucose; Forsk, forskolin. The inset shows the signal of a representative experiment. Data are means ± SE of four to five separate experiments. *P < 0.05.

    • FIG. 7.
      • Download figure
      • Open in new tab
      • Download powerpoint
      FIG. 7.

      Effect of oleate on UCP2 protein expression. INS-1 cells were cultured for 72 h with normal medium containing 0.5% BSA of BSA-oleate (0.4 mmol/l), and UCP2 was measured by Western blotting using 30 μg cell homogenate. Data are means of triplicate determinations. *P < 0.05.

    Tables

    • Figures
    • TABLE 1

      Effects of a long-term or short-term exposure of INS-1 cells to oleate on the ATP content and ATP-to-ADP ratio at low and high glucose

      Culture conditions
      ATP (nmole/μg DNA)ATP-to-ADP ratio
      Glucose (mmol/l)2.8122.812
       Long-term
        BSA 72 h0.420 ± 0.0480.480 ± 0.043*4.9 ± 0.18.3 ± 0.9†
        Oleate 0.4 mmol/l 72 h0.500 ± 0.0480.510 ± 0.0566.4 ± 0.26.7 ± 0.5
       Short-term
        BSA 15 min0.296 ± 0.0330.355 ± 0.029‡NDND
        Oleate 0.4 mmol/l 15 min0.216 ± 0.0210.329 ± 0.029§NDND
      • Data are means ± SE of four independent experiments.

      • *

        * P ≤ 0.02 vs. 2.8 mmol/l glucose;

      • †

        † P ≤ 0.05 vs. 2.8 mmol/l glucose;

      • ‡

        ‡ P < 0.02 vs. 2.8 mmol/l glucose by paired analysis; and

      • §

        § P < 0.01 vs. 2.8 mmol/l glucose + oleate by paired analysis. ND, not determined.

    PreviousNext
    Back to top

    In this Issue

    April 2001, 50(4)
    • Table of Contents
    • Index by Author
    Sign up to receive current issue alerts
    View Selected Citations (0)
    Print
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for your interest in spreading the word about Diabetes.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Uncoupling Protein 2: A Possible Link Between Fatty Acid Excess and Impaired Glucose-Induced Insulin Secretion?
    (Your Name) has forwarded a page to you from Diabetes
    (Your Name) thought you would like to see this page from the Diabetes web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Uncoupling Protein 2: A Possible Link Between Fatty Acid Excess and Impaired Glucose-Induced Insulin Secretion?
    Nathalie Lameloise, Patrick Muzzin, Marc Prentki, Françoise Assimacopoulos-Jeannet
    Diabetes Apr 2001, 50 (4) 803-809; DOI: 10.2337/diabetes.50.4.803

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
    Add to Selected Citations
    Share

    Uncoupling Protein 2: A Possible Link Between Fatty Acid Excess and Impaired Glucose-Induced Insulin Secretion?
    Nathalie Lameloise, Patrick Muzzin, Marc Prentki, Françoise Assimacopoulos-Jeannet
    Diabetes Apr 2001, 50 (4) 803-809; DOI: 10.2337/diabetes.50.4.803
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • RESEARCH DESIGN AND METHODS
      • RESULTS
      • DISCUSSION
      • Acknowledgments
      • Footnotes
      • REFERENCES
    • Figures & Tables
    • Info & Metrics
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • Glucagon Resistance and Decreased Susceptibility to Diabetes in a Model of Chronic Hyperglucagonemia
    • Acyl-Ghrelin Influences Pancreatic β-Cell Function by Interference with KATP Channels
    • Pancreatic β-Cell–Specific Deletion of VPS41 Causes Diabetes Due to Defects in Insulin Secretion
    Show more Islet Studies

    Similar Articles

    Navigate

    • Current Issue
    • Online Ahead of Print
    • Scientific Sessions Abstracts
    • Collections
    • Archives
    • Submit
    • Subscribe
    • Email Alerts
    • RSS Feeds

    More Information

    • About the Journal
    • Instructions for Authors
    • Journal Policies
    • Reprints and Permissions
    • Advertising
    • Privacy Policy: ADA Journals
    • Copyright Notice/Public Access Policy
    • Contact Us

    Other ADA Resources

    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • Scientific Sessions Abstracts
    • Standards of Medical Care in Diabetes
    • BMJ Open - Diabetes Research & Care
    • Professional Books
    • Diabetes Forecast

     

    • DiabetesJournals.org
    • Diabetes Core Update
    • ADA's DiabetesPro
    • ADA Member Directory
    • Diabetes.org

    © 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.